Evidence map›Paper›PMID 36104423›Full record

ArticleCommunications biology2022

Oral microbial extracellular DNA initiates periodontitis through gingival degradation by fibroblast-derived cathepsin K in mice.

Takeru Kondo, Hiroko Okawa, Akishige Hokugo, Bhumika Shokeen, Oskar Sundberg, Yiying Zheng, Charles E McKenna, Renate Lux, Ichiro Nishimura

Open access · goldAbstract read
In one paragraph

Article in Communications biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Osteocyte RANKL Drives Bone Resorption in Mouse Ligature-Induced Periodontitis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Takeru Kondo *Weintraub Center for Reconstructive Biotechnology, Division of Regenerative & Reconstructive Sciences, UCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Hiroko Okawa *Weintraub Center for Reconstructive Biotechnology, Division of Regenerative & Reconstructive Sciences, UCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Akishige HokugoWeintraub Center for Reconstructive Biotechnology, Division of Regenerative & Reconstructive Sciences, UCLA School of Dentistry, Los Angeles, CA, 90095, USA.ORCID 0000-0002-7097-3364
Bhumika ShokeenSection of Biosystems and Function, UCLA School of Dentistry, Los Angeles, CA, 90095, USA.
Oskar SundbergDepartment of Chemistry, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
Yiying ZhengDepartment of Chemistry, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, 90089, USA.
Charles E McKennaDepartment of Chemistry, Dana and David Dornsife College of Letters, Arts and Sciences, University of Southern California, Los Angeles, CA, 90089, USA.ORCID 0000-0002-3540-6663
Renate LuxSection of Biosystems and Function, UCLA School of Dentistry, Los Angeles, CA, 90095, USA.ORCID 0000-0003-3253-0471
Ichiro NishimuraWeintraub Center for Reconstructive Biotechnology, Division of Regenerative & Reconstructive Sciences, UCLA School of Dentistry, Los Angeles, CA, 90095, USA. inishimura@dentistry.ucla.edu.ORCID 0000-0002-3749-9445
University of Southern California · USTohoku University · JPRegenerative Medicine Institute · MXUniversity of California, Los Angeles · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Competitive Equilibrium-based Displacement of Bisphosphonates as Novel Therapeutic Approach for BRONJR44DE025524 · NIDCR · BIOVINC, LLC · PI EBETINO, FRANK H. · 2017 to 2018
$2.2M
Molecular and cellular mechanism of ONJ related to osteoclast inhibitionR21DE023410 · NIDCR · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MCKENNA, CHARLES E, NISHIMURA, ICHIRO · 2014 to 2015
$451k
EXTRAMURAL RESEARCH FACILITIES CONSTRUCTION PROJECTSC06RR014529 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PARK, NO-HEE · 1999 to 1999
–
NCI NIH HHS P30 CA016042NCRR NIH HHS C06 RR014529NIDCR NIH HHS R21 DE023410NIDCR NIH HHS R44 DE025524
6 · The paper itself

Abstract

Periodontitis is a highly prevalent disease leading to uncontrolled osteoclastic jawbone resorption and ultimately edentulism; however, the disease onset mechanism has not been fully elucidated. Here we propose a mechanism for initial pathology based on results obtained using a recently developed Osteoadsorptive Fluogenic Sentinel (OFS) probe that emits a fluorescent signal triggered by cathepsin K (Ctsk) activity. In a ligature-induced mouse model of periodontitis, a strong OFS signal is observed before the establishment of chronic inflammation and bone resorption. Single cell RNA sequencing shows gingival fibroblasts to be the primary cellular source of early Ctsk. The in vivo OFS signal is activated when Toll-Like Receptor 9 (TLR9) ligand or oral biofilm extracellular DNA (eDNA) is topically applied to the mouse palatal gingiva. This previously unrecognized interaction between oral microbial eDNA and Ctsk of gingival fibroblasts provides a pathological mechanism for disease initiation and a strategic basis for early diagnosis and treatment of periodontitis.

Indexed as

Bone ResorptionPeriodontitisAnimalsCathepsin KDNAFibroblastsGingivaMiceCathepsin KCtsk protein, mouseDNA

Identifiers

PMID36104423
PMCPMC9474870
OpenAlexW4295763100

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.